Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now presents the ClinicalTrials.gov record for a completed Phase 1/2 study of nivolumab alone or combined with ipilimumab, including study design, eligibility, locations, and results information.
    Difference
    77%
    Check dated 2026-11-07T15:55:58.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error instead of displaying the study record. The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T16:26:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:33:34.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T22:14:20.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the 403 error page otherwise remains unchanged.
    Difference
    0.2%
    Check dated 2026-10-10T22:11:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, with the HTML structure indicating a permissions denial, replacing the normal study content.
    Difference
    20%
    Check dated 2026-09-19T19:05:11.000Z thumbnail image

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.